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Conclusion: Patients with severe aortic stenosis and LV dysfunction undergoing TAVI
have worse 6-month survival outcomes than patients with normal LV function. In those
patients with LV dysfunction, a mean transaortic valve gradient <40 mmHg was
associated with a higher mortality than if the gradient was >40 mmHg.
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Background: Cerebrovascular accident (CVA) is a major adverse event in pts with
STEMI. The incidence and predictors of CVA in pts undergoing a primary PCI
management strategy have been incompletely characterized.
Methods: In the HORIZONS-AMI trial, following emergent coronary arteriography
in 3,602 pts with STEMI, the principal management was by PCI in 3347 (92.9%),
CABG in 64 (1.8%) and medical therapy in 189 (5.2%). A CVA during the 3-year
follow-up period developed in 72 pts(2.0%), including 63 (1.7%) who had a stroke
and 12 (0.3%) who had a transient ischemic attack (TIA). Three pts had both stroke
and TIA.
Results: The CVA occurred in 26 pts(36.1%) within 30 days, in 20 pts(27.8%) between
30 days and 1 year, and in 26 pts(36.1%) between 1 and 3 years. Stroke was ischemic
in origin in 58/63 pts (92.1%) and hemorrhagic in 5/63 pts (7.9%). By principle
management strategy, CVA developed in 1.8%, 14.1% and 1.6% pts triaged to primary
PCI, CABG and medical therapy, respectively (p=0.06). By multivariable analysis,
occurrence of CVA at 3 years was associated with older age (HR=1.72 per 10 years
increase, p=0.006), LVEF <40% (HR=2.59, p=0.04), and performance of CABG within
30 days (HR=5.49, p=0.002). CVA was associated with strikingly increased rates of
3-year mortality (20.5% vs. 6.5%, p<0.0001). The risk of 3-year mortality in pts with
CVA was greater in pts with true stroke compared to those only with TIA (22.2% vs.
0%, P=0.14), but was comparable in pts in whom the stroke etiology was ischemic vs.
hemorrhagic (22.4% vs. 20.0%, HR[95%CI]=1.08[0.14,8.25], p=0.94). In a time
updated covariate adjusted multivariable analysis, stroke was an independent predictor
of 3-year mortality (HR[95%CI]=2.11[1.15,3.89], p=0.02].
Conclusion: In pts with STEMI undergoing a primary PCI management strategy, the
risk of developing a CVA within 3 years is relatively low in those treated with PCI or
medical therapy after angiographic triage, but may be frequent after CABG. Ischemic
and hemorrhagic stroke after STEMI are associated with substantial mortality.
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Background: In patients with ST-segment elevation myocardial infarction (STEMI)
periods of ischemia assessed by angina preceding the infarction (pre-infarction angina),
pre-procedural TIMI flow and collateral flow to the infarct related artery are suggested
to be related to prognosis. We evaluated the effect of pre-infarction angina, pre-
procedural TIMI flow and collateral flow on myocardial salvage (MSI) by cardiac
magnetic resonance (CMR) in STEMI patients treated with primary percutaneous
coronary intervention.
Methods: In 198 patients with STEMI myocardial area at risk was measured within
1-7 days and final infarct size 90±21 days after STEMI. The primary endpoint was
MSI: (Area at risk – infarct size) / area at risk.
Results: Patients with one or more incidences of pre-infarction angina had higher MSI
than patients without (0.80 (IQR 0.67-0.86) versus 0.72 (0.61-0.80), p=0.005). MSI
was significantly different between pre-procedural TIMI flow groups 0/1, 2 and 3 (0.69
(0.59-0.76), 0.78 (0.68-0.86) versus 0.85 (0.77-0.91); p<0.001). Post-hoc analysis
showed that TIMI flow 0/1 had smaller MSI compared to TIMI flow 2 and 3 (p<0.01).
Furthermore, TIMI flow 2 was associated with smaller MSI than TIMI flow 3 (p<0.05).
Collateral flow did not change MSI (0.69 (0.59-0.76) versus 0.71 (0.65-0.78); p=0.45).
Conclusion: Pre-infarction angina increases MSI in STEMI patients supporting the
theory that pre-infarction angina leads to ischemic preconditioning. Pre-procedural
TIMI flow is an important predictor for MSI and patients with TIMI flow 2 is at
intermediary risk. Collateral flow does not change MSI.
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Background: Primary percutaneous coronary intervention (PPCI) is the preferred
reperfusion strategy for patients (pts) with ST-segment-elevation myocardial infarction
(STEMI), but some concerns still remain about its safety and efficacy in centers without
cardiac surgery on-site (SOS).
Methods: The Infermi Hospital is a community hospital with a high volume
catheterization laboratory (CL)(>800 total PCI and >150 PPCI/year) without SOS and
provides a network-wide PPCI service to a population of 583.000 in a 24/7/365 fashion
within easy reach of SOS hospitals in Turin city (14 Km). We collected data about all
consecutive pts with STEMI within 12 hours admitted to our CL and analyzed clinical
and procedural characteristics as well as in-hospital outcomes of pts who underwent
PPCI.
Results: From September 2001 to June 2010, 1302 STEMI pts underwent urgent
coronary angiography. Of these 45 (3.4%) did not present significant coronary artery
disease (CAD) and were managed medically; 6 (0.5%) presented severe CAD and were
sent to surgery and 1251 (96.1%, mean age 65±12 years, 25.1% females, 23%
diabetics) underwent PPCI. One hundred ninety-eight pts (15.8%) presented with shock
(CS). Procedural success was 93.7%. Overall in-hospital death (IHD) was 6.9%.
Multivariate predictors of IHD were: age ≥75 years (hazard ratio 3.96, 95% CI 1.89-
8.32, p=0.0003), ejection fraction <40% (hazard ratio 1.35, 95% CI 1.05-1.72, p=0.02),
CS at presentation (hazard ratio 33.40, 95% CI 11.10-100.44, p<0.0001), anterior
infarction (hazard ratio 1.82, 95% CI 1.04-3.17, p=0.036) and oro-tracheal intubation
(hazard ratio 37.04, 95% CI 6.0-228.45, p=0.0001). Total ischemic time ≤ 3 hours led
to a favorable outcome (hazard ratio 0.55, 95% CI 0.30-1.01, p=0.05).
Conclusion: PPCI is a reperfusion strategy feasible and effective in unselected high-
risk STEMI pts even in hospitals without SOS, provided that a high volume of routine
and emergency interventional procedures is maintained.
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Background: The beneficial role of adjunctive antithrombotic treatments, such as
manual thrombus aspiration (TA) and Glycoprotein IIb/IIIa inhibitors (GPI) was
previously confirmed in the setting of Primary Primary Percutaneous Coronary
Intervention (PPCI). Still, trials regarding GPI did not consider patients undergoing
TA, while all major studies on TA concerned patient populations prevalently treated
with GPI.
Methods: From January 2007 to December 2009, 448 STEMI patients were
consecutively enroled according to a 2×2 factorial design into 1 of the 4 groups:
standard PPCI, PCI with thrombus aspiration (TA), PPCI with GPI infusion, and PPCI
with both treatments (TA+GPI).
Results: . A post procedural TIMI flow 2-3 was present in 91% in the standard PPCI
group, 95% in the GPI group, 95% in the TA group, and 98.8% in the TA+GPI group
(p=0.026). At 30 days of follow up, the cumulative incidence of death and re-infarction
was 5% in patients treated TA and GPI, 10% in patients treated with only TA, 15% in
patients treated only with GPI, and 16% in patients treated with standard PPCI
(p=0.036). Long term mortality differed significantly between patients treated with
both TA and GPI and patients treated with standard PPCI (7% vs 17.2%, p=0.012). At
multivariate analysis, age (HR 1.058, CI 1.015-1.103, p=0.008), III-IV Killip Class
(HR 12.663, CI 4.772-33.602, p<0.001), TA (HR 0.355, CI 0.138-0.914, p=0.032), left
ventricular ejection fraction<45% (HR 4.787, CI 1.941-11.807, p=0.001), and increased
CK-MB values (HR 1.002, CI 1-1.003, p=0.007) emerged as independent predictors
for overall mortality.
Conclusion: In STEMI patients undergoing PPCI, the combined application of
thrombus aspiration and abciximab was associated with lower short term mortality and
reinfarction rates and with an improved long term outcome. TA, but not GPI, emerged
as an independent predictor of long term survival.
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